Picture of Ryvu Therapeutics SA logo

RVU Ryvu Therapeutics SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Ryvu Therapeutics Says Its Project Recommended For Funding By Poland's PARP

March 27 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * SAYS RYVU PROJECT RECOMMENDED FOR FUNDING BY POLISH AGENCY
FOR
ENTERPRISE DEVELOPMENT
    * TOTAL VALUE OF PROJECT AT 39.2 MILLION ZLOTYS
    * RECOMMENDED VALUE OF SUBSIDY AT 26.3 MILLION ZLOTYS
    * ONCO PRIME PROJECT RELATED TO ANTICANCER THERAPY

Source text for Workspace:  ID:nEM1bmJ9pa 
Further company coverage:  RVU.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

Recent news on Ryvu Therapeutics SA

See all news